Spotlight on studies and news

Spotlight on studies and news

Catch up on all the latest research news via the links below:


REDEFINE 3 Image from novo nordisk

The study, REDEFINE 3, is looking at a combination of two medicines. REDEFINE 3 is needed to help us understand how effective these two medicines are for reducing cardiovascular events, such as heart attacks and stroke. This study is funded and sponsored by Novo Nordisk. To find out more about the REDEFINE-3 study, please visit or contact the team:

01392 406289

Find out more

E.mbrace; Investigational research study at the PRC: Exeter

E.mbrace study campaign image

The PRC Exeter (Based on the Wonford site at the Royal Devon) are currently looking for participants for a clinical research study to assess the effectiveness and safety of an investigational vaccine in the prevention of bloodstream infections. 

People aged 60 years or older with a history of urinary tract infection (UTI) are at an increased risk of developing a bloodstream infection caused by E. coli bacteria.

If you are interested, or you know someone who might be, please let them know about the study and share the contact details below. Further information on the study can also be found here.

You may be eligible to participate in this study if you:

  • Are 60 years of age or older
  • Have had a UTI in the past 2 years
  • Feel comfortable, or have a caregiver who is comfortable, using an application on a smartphone

Find out more

Last updated: March 14, 2024


Our site uses cookies to help give you a better experience. By continuing to use it you consent to the use of cookies as set out in our privacy policy.